Positron emission tomography to assess hypoxia and perfusion in lung cancer.

作者: Eline E Verwer , Ronald Boellaard , Astrid AM van der Veldt

DOI: 10.5306/WJCO.V5.I5.824

关键词:

摘要: In lung cancer, tumor hypoxia is a characteristic feature, which associated with poor prognosis and resistance to both radiation therapy chemotherapy. As the development of decreased perfusion, perfusion measurements provide more insight into relation between in malignant tumors. Positron emission tomography (PET) highly sensitive nuclear imaging technique that suited for non-invasive vivo monitoring dynamic processes including its parameter perfusion. The PET enables quantitative assessment To this end, consecutive scans can be performed one scan session. Using different tracers, may prognostic significance cancer. addition, studies play an important role various stages personalized medicine, as these help select patients specific treatments therapy, modifying therapies, antiangiogenic strategies. tracers applied therapy. present review provides overview clinical applications measure Available their characteristics well combined are discussed.

参考文章(250)
S Loi, S Y K Ngan, R J Hicks, B Mukesh, P Mitchell, M Michael, J Zalcberg, T Leong, D Lim-Joon, J Mackay, D Rischin, Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial British Journal of Cancer. ,vol. 92, pp. 655- 661 ,(2005) , 10.1038/SJ.BJC.6602413
Zhang Xiangsong, Wu Xinjian, Zhang Yong, Chen Weian, 13N-NH3: a selective contrast-enhancing tracer for brain tumor. Nuclear Medicine Communications. ,vol. 29, pp. 1052- 1058 ,(2008) , 10.1097/MNM.0B013E328310AF34
Janet S. Rasey, Wui-jin Koh, Margaret L. Evans, Lanell M. Peterson, Thomas K. Lewellen, Michael M. Graham, Kenneth A. Krohn, Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients International Journal of Radiation Oncology Biology Physics. ,vol. 36, pp. 417- 428 ,(1996) , 10.1016/S0360-3016(96)00325-2
G Esther, C Troost, Peter Laverman, E Mariëlle, P Philippens, Jasper Lok, Albert J van der Kogel, J Wim, G Oyen, Otto C Boerman, H Johannes, M Kaanders, Johan Bussink, Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 35, pp. 1803- 1811 ,(2008) , 10.1007/S00259-008-0772-7
Catharina M.L. Zegers, Wouter van Elmpt, Roel Wierts, Bart Reymen, Hoda Sharifi, Michel C. Öllers, Frank Hoebers, Esther G.C. Troost, Rinus Wanders, Angela van Baardwijk, Boudewijn Brans, Jonas Eriksson, Bert Windhorst, Felix M. Mottaghy, Dirk De Ruysscher, Philippe Lambin, Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters Radiotherapy and Oncology. ,vol. 109, pp. 58- 64 ,(2013) , 10.1016/J.RADONC.2013.08.031
Shin-Hwa Yeh, Ren-Shyan Liu, Liang-Chih Wu, David J. Yang, Sang-Hue Yen, Chi-Wei Chang, Tong-Wei Yu, Kou-Liang Chou, Kuang Y. Chen, Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 23, pp. 1378- 1383 ,(1996) , 10.1007/BF01367595
Farrokh Dehdashti, Mark A. Mintun, Jason S. Lewis, Jeffrey Bradley, Ramaswamy Govindan, Richard Laforest, Michael J. Welch, Barry A. Siegel, In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 30, pp. 844- 850 ,(2003) , 10.1007/S00259-003-1130-4
Matthias Schuetz, Maximilian P. Schmid, Richard Pötter, Spyridoula Kommata, Dietmar Georg, Dobrica Lukic, Robert Dudczak, Kurt Kletter, Johannes Dimopoulos, Georgios Karanikas, Barbara Bachtiary, Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncologica. ,vol. 49, pp. 941- 947 ,(2010) , 10.3109/0284186X.2010.510145
Bernd Gagel, Marc Piroth, Michael Pinkawa, Patrick Reinartz, Michael Zimny, Hans J Kaiser, Sven Stanzel, Branka Asadpour, Cengiz Demirel, Kurt Hamacher, Heinz H Coenen, Thomas Scholbach, Payam Maneschi, Ercole DiMartino, Michael J Eble, pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer. ,vol. 7, pp. 113- 113 ,(2007) , 10.1186/1471-2407-7-113